MXPA00012387A - Synthesis of benzo[f]quinolinones - Google Patents
Synthesis of benzo[f]quinolinonesInfo
- Publication number
- MXPA00012387A MXPA00012387A MXPA/A/2000/012387A MXPA00012387A MXPA00012387A MX PA00012387 A MXPA00012387 A MX PA00012387A MX PA00012387 A MXPA00012387 A MX PA00012387A MX PA00012387 A MXPA00012387 A MX PA00012387A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- formula
- alkyl
- reacting
- halo
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title description 12
- YYWLMFCICDCVKT-UHFFFAOYSA-N 2H-benzo[f]quinolin-1-one Chemical class C1=CC=CC2=C3C(=O)CC=NC3=CC=C21 YYWLMFCICDCVKT-UHFFFAOYSA-N 0.000 title description 8
- 238000003786 synthesis reaction Methods 0.000 title description 8
- 230000002194 synthesizing Effects 0.000 title description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- -1 2-Nitrophenyl Chemical group 0.000 claims description 189
- 150000001875 compounds Chemical class 0.000 claims description 73
- YMWUJEATGCHHMB-UHFFFAOYSA-N methylene dichloride Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 46
- 238000006243 chemical reaction Methods 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 29
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 28
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 24
- 239000002904 solvent Substances 0.000 claims description 24
- 239000003153 chemical reaction reagent Substances 0.000 claims description 21
- 239000011541 reaction mixture Substances 0.000 claims description 20
- IHNINSVQYKIZIC-UHFFFAOYSA-N 2H-quinolin-3-one Chemical compound C1=CC=CC2=CC(=O)CN=C21 IHNINSVQYKIZIC-UHFFFAOYSA-N 0.000 claims description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 16
- 125000005843 halogen group Chemical group 0.000 claims description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 14
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims description 14
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 14
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 13
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 13
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N Thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 10
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 10
- WQOXQRCZOLPYPM-UHFFFAOYSA-N Dimethyl disulfide Chemical group CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 claims description 9
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 9
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 8
- PYOKUURKVVELLB-UHFFFAOYSA-N Trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 claims description 8
- 229910052744 lithium Inorganic materials 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 8
- 239000011593 sulfur Substances 0.000 claims description 8
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000001589 carboacyl group Chemical group 0.000 claims description 7
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- 150000002367 halogens Chemical group 0.000 claims description 6
- WHXSMMKQMYFTQS-UHFFFAOYSA-N lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- ARJOQCYCJMAIFR-UHFFFAOYSA-N prop-2-enoyl prop-2-enoate Chemical compound C=CC(=O)OC(=O)C=C ARJOQCYCJMAIFR-UHFFFAOYSA-N 0.000 claims description 6
- BLRPTPMANUNPDV-UHFFFAOYSA-N silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 6
- 229910000077 silane Inorganic materials 0.000 claims description 6
- MNCMBBIFTVWHIP-UHFFFAOYSA-N 1-anthracen-9-yl-2,2,2-trifluoroethanone Chemical group C1=CC=C2C(C(=O)C(F)(F)F)=C(C=CC=C3)C3=CC2=C1 MNCMBBIFTVWHIP-UHFFFAOYSA-N 0.000 claims description 5
- QOWSWEBLNVACCL-UHFFFAOYSA-N 4-Bromophenyl acetate Chemical compound OC(=O)CC1=CC=C(Br)C=C1 QOWSWEBLNVACCL-UHFFFAOYSA-N 0.000 claims description 5
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims description 5
- 150000001266 acyl halides Chemical class 0.000 claims description 5
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 5
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims description 5
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 5
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 5
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 5
- 125000006576 di-(C1-C3-alkyl)-aminocarbonyl group Chemical group 0.000 claims description 5
- 150000002170 ethers Chemical class 0.000 claims description 5
- 125000001475 halogen functional group Chemical group 0.000 claims description 5
- 125000004043 oxo group Chemical group O=* 0.000 claims description 5
- BYHKDUFPSJWJDI-UHFFFAOYSA-N 6-bromo-3,4-dihydro-1H-naphthalen-2-one Chemical compound C1C(=O)CCC2=CC(Br)=CC=C21 BYHKDUFPSJWJDI-UHFFFAOYSA-N 0.000 claims description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N Oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 claims description 4
- 125000004414 alkyl thio group Chemical group 0.000 claims description 4
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 239000003054 catalyst Substances 0.000 claims description 4
- 150000002576 ketones Chemical class 0.000 claims description 4
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims description 4
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000003652 trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 4
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 claims description 3
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 239000012039 electrophile Substances 0.000 claims description 3
- KLGZELKXQMTEMM-UHFFFAOYSA-N hydride Chemical compound [H-] KLGZELKXQMTEMM-UHFFFAOYSA-N 0.000 claims description 3
- 239000011968 lewis acid catalyst Substances 0.000 claims description 3
- 230000001035 methylating Effects 0.000 claims description 3
- 230000001590 oxidative Effects 0.000 claims description 3
- 239000003444 phase transfer catalyst Substances 0.000 claims description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching Effects 0.000 claims description 3
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 2
- 239000005977 Ethylene Substances 0.000 claims description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N Phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N Phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 claims description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 238000006778 Pummerer Sulfoxide rearrangement reaction Methods 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000006604 di(C1-C3 alkyl) aminosulfonyl group Chemical group 0.000 claims 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 2
- 125000004455 (C1-C3) alkylthio group Chemical group 0.000 claims 1
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000001246 bromo group Chemical group Br* 0.000 claims 1
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- 239000000543 intermediate Substances 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 3
- YEXWPTQVHNJMNW-UHFFFAOYSA-N 2H-benzo[h]quinolin-3-one Chemical compound C1=CC=C2C=CC3=CC(=O)CN=C3C2=C1 YEXWPTQVHNJMNW-UHFFFAOYSA-N 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 51
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- 239000000203 mixture Substances 0.000 description 42
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 40
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 33
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 23
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- ZCSHNCUQKCANBX-UHFFFAOYSA-N Lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 18
- 235000017557 sodium bicarbonate Nutrition 0.000 description 16
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 16
- 239000010410 layer Substances 0.000 description 14
- 238000002360 preparation method Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 12
- 239000007787 solid Substances 0.000 description 12
- 238000010992 reflux Methods 0.000 description 11
- 239000007858 starting material Substances 0.000 description 11
- 238000003756 stirring Methods 0.000 description 11
- UAOMVDZJSHZZME-UHFFFAOYSA-N Diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 10
- INQOMBQAUSQDDS-UHFFFAOYSA-N Methyl iodide Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 10
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N Trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
- 238000007792 addition Methods 0.000 description 10
- 238000005804 alkylation reaction Methods 0.000 description 9
- 239000002808 molecular sieve Substances 0.000 description 9
- KWYUFKZDYYNOTN-UHFFFAOYSA-M potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N MeOtBu Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 150000003462 sulfoxides Chemical class 0.000 description 8
- AFVFQIVMOAPDHO-UHFFFAOYSA-N methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 7
- 239000012044 organic layer Substances 0.000 description 7
- 238000000746 purification Methods 0.000 description 7
- 230000002829 reduced Effects 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000004817 gas chromatography Methods 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000000741 silica gel Substances 0.000 description 6
- 229910002027 silica gel Inorganic materials 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- YOQDYZUWIQVZSF-UHFFFAOYSA-N sodium borohydride Substances [BH4-].[Na+] YOQDYZUWIQVZSF-UHFFFAOYSA-N 0.000 description 6
- 229910000033 sodium borohydride Inorganic materials 0.000 description 6
- ODGROJYWQXFQOZ-UHFFFAOYSA-N sodium;boron(1-) Chemical compound [B-].[Na+] ODGROJYWQXFQOZ-UHFFFAOYSA-N 0.000 description 6
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 description 6
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical class CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 5
- NQOWVESUHAQWMO-UHFFFAOYSA-N 2-chloro-4-ethyl-1,3-benzothiazole Chemical group CCC1=CC=CC2=C1N=C(Cl)S2 NQOWVESUHAQWMO-UHFFFAOYSA-N 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N P-Toluenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 230000001808 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 239000008367 deionised water Substances 0.000 description 5
- 229940043279 diisopropylamine Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000008079 hexane Substances 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 238000004949 mass spectrometry Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 238000005292 vacuum distillation Methods 0.000 description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N Meta-Chloroperoxybenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 150000001351 alkyl iodides Chemical class 0.000 description 4
- 125000000477 aza group Chemical group 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N benzohydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 238000005755 formation reaction Methods 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N n-heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- 239000001184 potassium carbonate Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 4
- HFBMWMNUJJDEQZ-UHFFFAOYSA-N Acryloyl chloride Chemical compound ClC(=O)C=C HFBMWMNUJJDEQZ-UHFFFAOYSA-N 0.000 description 3
- 150000002081 enamines Chemical class 0.000 description 3
- 150000002642 lithium compounds Chemical class 0.000 description 3
- 229940098779 methanesulfonic acid Drugs 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L na2so4 Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- BZKBCQXYZZXSCO-UHFFFAOYSA-N sodium hydride Chemical compound [H-].[Na+] BZKBCQXYZZXSCO-UHFFFAOYSA-N 0.000 description 3
- 229910052938 sodium sulfate Inorganic materials 0.000 description 3
- 235000011152 sodium sulphate Nutrition 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- BHHGXPLMPWCGHP-UHFFFAOYSA-N 2-Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- WALVUGBRQYPZFQ-UHFFFAOYSA-N 6-methyl-3,4-dihydro-1H-naphthalene-2-thione Chemical compound C1C(=S)CCC2=CC(C)=CC=C21 WALVUGBRQYPZFQ-UHFFFAOYSA-N 0.000 description 2
- GZUXJHMPEANEGY-UHFFFAOYSA-N Bromomethane Chemical compound BrC GZUXJHMPEANEGY-UHFFFAOYSA-N 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 101700067048 CDC13 Proteins 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N Nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N Potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- NVBFHJWHLNUMCV-UHFFFAOYSA-N Sulfamide Chemical compound NS(N)(=O)=O NVBFHJWHLNUMCV-UHFFFAOYSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 239000011260 aqueous acid Substances 0.000 description 2
- 125000005605 benzo group Chemical group 0.000 description 2
- HCAUQPZEWLULFJ-UHFFFAOYSA-N benzo[f]quinoline Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=N1 HCAUQPZEWLULFJ-UHFFFAOYSA-N 0.000 description 2
- 239000012455 biphasic mixture Substances 0.000 description 2
- CROBTXVXNQNKKO-UHFFFAOYSA-N borohydride Chemical group [BH4-] CROBTXVXNQNKKO-UHFFFAOYSA-N 0.000 description 2
- 239000012267 brine Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- QGJOPFRUJISHPQ-UHFFFAOYSA-N carbon bisulphide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000006138 lithiation reaction Methods 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 238000005192 partition Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000012258 stirred mixture Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- MEFKFJOEVLUFAY-UHFFFAOYSA-N (2,2,2-trichloroacetyl) 2,2,2-trichloroacetate Chemical compound ClC(Cl)(Cl)C(=O)OC(=O)C(Cl)(Cl)Cl MEFKFJOEVLUFAY-UHFFFAOYSA-N 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000006656 (C2-C4) alkenyl group Chemical group 0.000 description 1
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N 1,1-Diethoxyethane Chemical compound CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- WAKFRZBXTKUFIW-UHFFFAOYSA-N 2-bromo-2-phenylacetic acid Chemical compound OC(=O)C(Br)C1=CC=CC=C1 WAKFRZBXTKUFIW-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N Acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- PQLAYKMGZDUDLQ-UHFFFAOYSA-K Aluminium bromide Chemical compound Br[Al](Br)Br PQLAYKMGZDUDLQ-UHFFFAOYSA-K 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- FAPDDOBMIUGHIN-UHFFFAOYSA-K Antimony trichloride Chemical compound Cl[Sb](Cl)Cl FAPDDOBMIUGHIN-UHFFFAOYSA-K 0.000 description 1
- 229940095259 Butylated Hydroxytoluene Drugs 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate dianion Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N Chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N Dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229910005267 GaCl3 Inorganic materials 0.000 description 1
- UPWPDUACHOATKO-UHFFFAOYSA-K Gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K Iron(III) chloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 229940050176 Methyl Chloride Drugs 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N N,N-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 210000000282 Nails Anatomy 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N Nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 210000004940 Nucleus Anatomy 0.000 description 1
- 229940117803 Phenethylamine Drugs 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N Phosphorus pentoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 238000006956 Pummerer reaction Methods 0.000 description 1
- 229940100996 SODIUM BISULFATE Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M Sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L Sulphite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 229960003604 Testosterone Drugs 0.000 description 1
- HPGGPRDJHPYFRM-UHFFFAOYSA-J Tin(IV) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 description 1
- DUNKXUFBGCUVQW-UHFFFAOYSA-J Zirconium(IV) chloride Chemical compound Cl[Zr](Cl)(Cl)Cl DUNKXUFBGCUVQW-UHFFFAOYSA-J 0.000 description 1
- 229910007932 ZrCl4 Inorganic materials 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 201000004384 alopecia Diseases 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 229960003473 androstanolone Drugs 0.000 description 1
- 238000010719 annulation reaction Methods 0.000 description 1
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000005712 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- PBGGNZZGJIKBMJ-UHFFFAOYSA-N di(propan-2-yl)azanide Chemical compound CC(C)[N-]C(C)C PBGGNZZGJIKBMJ-UHFFFAOYSA-N 0.000 description 1
- 150000001354 dialkyl silanes Chemical class 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000002019 disulfides Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- IMROMDMJAWUWLK-UHFFFAOYSA-N ethenol Chemical compound OC=C IMROMDMJAWUWLK-UHFFFAOYSA-N 0.000 description 1
- HZNQVAOLVRFZBE-UHFFFAOYSA-N ethenylcyclohexane Chemical group C=C[C]1CCCCC1 HZNQVAOLVRFZBE-UHFFFAOYSA-N 0.000 description 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxyl anion Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 238000011031 large scale production Methods 0.000 description 1
- 235000020130 leben Nutrition 0.000 description 1
- 125000005647 linker group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- NZTNZPDOBQDOSO-UHFFFAOYSA-N lithium;boron(1-) Chemical compound [Li+].[B-] NZTNZPDOBQDOSO-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940102396 methyl bromide Drugs 0.000 description 1
- XGZVLEAZGCUUPH-UHFFFAOYSA-N methylamino(methylimino)methanesulfonic acid Chemical compound CNC(=NC)S(O)(=O)=O XGZVLEAZGCUUPH-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003472 neutralizing Effects 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000002900 organolithium compounds Chemical class 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 238000005020 pharmaceutical industry Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- HHUJLKPGQMFFMS-UHFFFAOYSA-N potassium;boron(1-) Chemical compound [B-].[K+] HHUJLKPGQMFFMS-UHFFFAOYSA-N 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- OENLEHTYJXMVBG-UHFFFAOYSA-N pyridine;hydrate Chemical compound [OH-].C1=CC=[NH+]C=C1 OENLEHTYJXMVBG-UHFFFAOYSA-N 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 125000004354 sulfur functional group Chemical group 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
A process for preparing intermediates and benzoquinolin-3-one pharmaceuticals, such pharmaceuticals are effective in treating conditions consequent on 5&agr;-reductase.
Description
SYNTHESIS OF BENZO [F] QUINOLINONAS
Field of Invention
The present invention pertains to the fields of organic chemistry, pharmaceutical chemistry and chemical manufacturing, and provides a convenient and economical process for preparing benzo [f] quinolinones which are useful as inhibitors of 5a-reductase and provides intermediates for the preparation of such pharmacists.
Background of the Invention
A currently active field of pharmaceutical resources is the inhibition of 5a-reduct asa, the enzyme that converts testosterone to dihydro-testosterone, a more powerful androgen. It has been shown that inhibitors of 5a-reductase can block the formation of dihydrot these terones and improve a number of highly undesirable conditions, including family baldness in men and benign prosthetic hypertrophy. Audia and collaborators, has
Ref. 125680 describes a series of Benzo [f] quinolinone compounds which are inhibitors of 5a-reductase. See: U.S. Patents 5,239,075 and
,541,190; I do not. Le t. , 44, 7001 (1993); J. Med. Ch em. , 3 6, 421 (1993); and European Patent Publication 0703221.
Description of the invention.
The present invention provides a novel process for the preparation of benzo [f] quinolinones which are effective inhibitors of 5a-reductase. The present process is more efficient than previous processes and is sensitive to large-scale synthesis. This invention also provides intermediary compounds for the preparation of such pharmaceuticals.
The present invention provides a novel process for preparing benzo [f] quinolinones and provides intermediates useful in the preparation of benzo [f] quinolinones. More specifically, the present invention is directed to a process for preparing a compound of the formula I
where R1 represents:
2 - . 2-nitrophenyl, 4-nitrophenyl, 2-cyanophenyl, 4-cyanophenyl, 2-n-t-ronaphthyl, -n-t-ronaphthyl 2-cyanonaphthyl, -cyanonaphthyl, 2-quinolinyl, 4-quinolinyl, 7- ? uinolini lo, 1-isoquinolinilo, 3-isoquinolinilo, 8 -i soquinolini lo, 2-quinoxalini lo, 2-benzot iazol ilo, 3- lH-inda zoli lo, 2-benzoxa zol ilo, 3- 1, 2-benzoisot ia zolyl, 2-pyridinyl, 4-pyridinyl, 2-pyrazinyl, 2-naphtho [2,3-d] thiazolyl. 2 -na fto [1, 2 -d] t iazoli lo, 9-anthryl, 2-thiazolyl, 2-benzimidazolyl, 1-benz [g] isoqumo inyl, 8 -benz [g] isoquinolinyl, 5-lH-tet razolij -o, 2 -quinazolinyl, 2-t-azolo [4, 5-b] pyridinyl, 4-10H-pyridazino [3,2-b] -2-quinazolinyl, 2-1, -benzodioxinyl, 2-triazine, 2- benzoxazino, 4-benzoxazino, 2-purine or 8-purine;
wherein the above R1 groups are substituted or unsubstituted with 1-3 functionalities selected from the group consisting of trifluoromethyl, trifluoroethoxy, C? -C4 alkyl, trifluoromethoxy, hydroxy, C? -C3 alkoxy, nitro, C? -C3 alkylthio, C 1 -C 3 alkanoyl, phenyl, oxo, phenoxy, phenylthio, C 1 -C 3 alkylsulphyl, C 1 -C 3 alkylsulfonyl, cyano, amino, C 1 -C 3 alkylamino, diphenylmet ylamino, t-rifenylmethylamino, benzyloxy, benzylthio, (mono- halo, nitro or CF3) benzyl (oxy or thio), di (C? -C3 alkyl, C3-C6 cycloalkyl, or C-C8 cycloalkylalkyl) amino, (monoC? -C3 alkyl, C1-C3 alkoxy or halo)
(phenyl, phenoxy, phenylthio, phenylsul fonyl or phenoxysulfonyl), C2-C6 alkanoylamino, benzoylamino, di phenylmethylamino (C1-C3 alkyl), aminocarbonyl, C1-C3 alkylaminocarbonyl, di (C1-C3 alkyl) aminocarbonyl, halo-alkanoyl Cj C6, aminosul fonilo, alkylaminosul fonilo C1-C3, di (C? -C3 alkyl) aminosulfon, phenyl (oxy or thio) (C1-C3 alkyl), (halo, C1-C3 alkyl, or C1-6 alkoxy) C3) phenyl (oxy or thio) (C 1 -C 3 alkyl), benzoyl, or (amino, C 1 -C 3 alkylamino, or di (C 3) alkyl) amino (C 1 -C 3 alkyl).
One aspect of the invention comprises converting a ketone of the formula
wherein R is halogen, preferably bromine;
to a protected ether, preferably using trimethyl orthoformate in methanol in the presence of a catalyst acid;
reacting the protected ether with an alkyl lithium reactive compound, such as, n-butyllithium and a sulfur transfer reagent, such as dimethyl disulfide, to provide an S-methylated ether compound; and deprotecting the S-methylated ether compound to provide a met ilt iotet ralone compound of the formula II
According to another aspect, the invention comprises converting the compound of formula II to a compound of formula I. One such preferred process comprises reacting the compound of formula II with (R) - (+) - phenethylamine to provide a compound of formula III
H- reacting the compound of the formula III with a strong lithium base to provide a lithium-enamine compound of the formula IV
methylating the resulting lithioanamine of formula IV to a compound of formula V, for example, reacting the resulting lithioenamine with methyl iodide in an ether solvent to prepare the compound of formula V
reacting the compound of the formula V with an acyl halide or an acrylic acid anhydride to prepare a compound of the formula VI
quenching the reaction with a base, and combining the residue comprising the compound of formula VI with an appropriate silane and trifluoroacetic acid in the absence of a solvent to prepare a compound of formula VII
by reacting the compound of the formula VII with a methyl halide, for example, methyl iodide in a reaction mixture comprising an organic solvent and a strong base to provide an arylmethylsulphide compound of the formula VIII
oxidizing the compound of the formula VIII for a sulphide compound of the formula IX
reacting the sulfoxide compound of formula IX with an acylating agent to provide a Pummerer reconfiguration product;
reacting the re-configuration product Pummerer with ur electrophile selected from the group consisting of A-R1 wherein A is a starting group and R1 represents:
2-nitrophenyl, 4-nitrophenyl, 2-cyanophenyl, 4-cyanophenyl, 2-nit ronaphthyl, 4-nitrophthyl, 2-cyanonaphthyl, 4-cyanonaphthyl, 2-quinolinyl, 4-quinolinyl, 7-quinolinyl, 1- isoquinol inyl, 3-isoquinolinyl, 8-isoquinolinyl, 2-quinoxalinyl, 2-benzothiazolyl, 3- IH-indazolyl, 2-benzoxazolyl, 3-1,2-benzisothiazolyl, 2-pyridinyl, 4-pyridinyl, -pyrazinyl, 2-naphtho [2,3-d] thiazolyl, 2-naphtho [1,2-d] thiazolyl, 9-anthryl, 2-thiazolyl, 2-benzimide zolyl, 1-benz [g] isoquinolinyl, 8- benz [g] isoquinolinyl, 5-lH-t et razol ilo, 2 -quina zolinilo, 2-t iazolo [4, 5-b] piridinil, 4-10H-piridazino [3,2-b] -2-quinazolinil, 2-1,4-benzodioxinyl, 2-triazine, 2-benzoxazine, 4-benzoxazine, 2-purine or 8-purine;
wherein the above R1 groups are substituted or unsubstituted with 1-3 groups selected from the group consisting of trifluoromethyl, tri-f-loredoxy, C1-C-alkyl, trifluoromethoxy, hydroxy, C1-C3-alkoxy, nitro, Cilt-C3 alkylthio , C 1 -C 3 alkanoyl, phenyl, oxo, phenoxy, phenylthio, C 1 -C 3 alkylsulfinyl, C 1 -C 3 alkylsulfonyl, cyano, amino, C 1 -C 3 alkylamino, diphenylmethylamino, triphenylmethylamino, benzyloxy, benzylthio, (mono-halo, nitro or CF 3 ) benzyl (oxy or thio), di (C 1 -C 3 alkyl, C 3 -C 6 cycloalkyl, or cycloalkylalkyl C -Clala, (mono-C 1 -C 3 alkyl, C 1 -C 3 alkoxy, or halo) (phenyl, phenoxy, phenylthio , phenylsulfonyl or phenoxysulfonyl), C2-C6 alkanoylamino, benzoylamino, diphenylmetylamino (C1-C3 alkyl), aminocarbonyl, C1-C3 alkylaminocarbonyl, di (C1-C3 alkyl) aminocarbonyl, halo-alkanoyl Ci-Ce, aminosulfonyl, alkylaminosulfonyl C1 -C3, di (C1-C3 alkyl) aminosulfon, phenyl (oxy or thio) (C1-C3 alkyl), (halo, C1-C3 alkyl or C6-C3 alkoxy) phenyl (oxy or thio) ) (C1-C3 alkyl), benzoyl, or
(amino, C1-C3 alkylamino or di (C1-C3 alkyl) amino)
(C1-C3 alkyl); in the presence of a phase transfer catalyst, a reagent reductive hydride reductant and a base, to prepare a compound of formula I.
Preferred intermediates of the present invention have the formulas:
The starting materials for the compounds in the claimed process whether they are commercially available, are known in the art, or can be prepared by methods known in the art, for example, see: Audia et al., In U.S. Pat. 5,239,075, published August 24, 1993 and European Patent Publication 0703221.
Throughout this document, all temperatures are described in degrees centigrade and all expressions of concentration, percentage and proportion are expressed in units of weight, except for solvent mixtures, which are described in units of volume, unless established otherwise.
References to the compounds herein include the pharmaceutically acceptable salts of such compounds, unless stated otherwise.
The different positions in the benzo [f] quinoline ring are indicated below.
The spatial configuration of the group in 10b and the hydrogen atom in 4a is required. The reader should understand that many of the compounds may exist in two or more stereochemical forms, and that all stereochemical forms are included in the present invention. In some of the compounds prepared or described below, simple enantiomers are prepared in pure form and are identified by the (+) or (-) nomenclature. In other cases, the mixture of diastereomers is prepared.
The group S-R1 occupies position 8.
The term "halogen" and "halo" include chlorine, bromine, fluorine and iodine.
Different alkyl groups, such as C 1 -C 4 alkyl and the like include groups such as methyl, ethyl, propyl, isopropyl, t-butyl, n-butyl and isobutyl. The alkenyl and alkylo groups constitute linking groups that are bivalent and bind to two other groups. For example, C2-C4 alkenyl includes ethenyl, 2-propenyl, 3-butenyl and 2-butenyl; and C2-C4 alkynyl includes, for example, ethynyl, 2-propynyl, 2-butynyl, and iso-2-butymyl.
The C6-C6 alkanoyl group includes such groups as formyl, acetyl, propionyl, isobutyryl, 2-ethylpropionyl and hexanoyl. The C3-C6 cycloalkyl group includes cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl, and the cycloalkylalkyl group C4-Ce includes, for example, cyclopropylmethyl, cyclohexylethyl, cyclobutylbutyl and cyclohexylmethyl.
Terms such as halo -C 1 -C 6 alkanoyl, halophenyl or C 1 -C 3 alkylphenyl refers to the indicated basic group having substitutions in their halo 1, 2 or 3 or C 1 -C 3 alkyl groups as can be described in the individual case.
The present process that prepares compounds of formula I has all the benzo [f] quinoline nuclei, in the benzo ring which is replaced by a cyclic R1 group linked to the benzoquinoline through a sulfur bond. The R1 groups can be substituted with additional organic groups, and can have at most three of said substituent groups. Many of the substituents may be the same or may be different.
Certain aspects of the process are preferred and will be specifically mentioned below. It will be understood that the following aspects are each individually important, and also that the preferred aspects can be combined to create preferred, more limited, more expanded, additional aspects.
Synthesis of 6-met ilt io-2-tetralona.
The starting material for the synthesis of 6-methylthio-2-tetralone is a 4-halophenylacetic acid (bromophenylacetic acid can be used for an example). 4-Bromophenylacetic acid is commercially available
(Aldrich Catalog Handbook of Fine Chemicals 1994- 5, page 233) or can be prepared by procedures well known to those skilled in the art. 4-Bromophenylacetic acid is used to prepare 6-bromo-2-tet ralone.
6-bromo-2-ethyl ralone is prepared by reacting 4-bromo-phenylacetic acid with thionyl chloride, phosphorus trichloride, oxalyl chloride, or phosphorus pentachloride, under conditions known to those skilled in the art, to provide 4-bromophenacetyl chloride (Scheme 1). Preferably, thionyl chloride and methylene chloride are used to provide the 4-bromophenacetyl chloride. By means of a Friedel-Craft acylation reaction of 4-bromophenacetyl chloride with ethylene gas in the presence of a Lewis acid catalyst and an inert or substantially inert solvent or a mixture of solvents, ring closure is carried out for provide ß-bromo-2-tetralone.
SCHEME 1
Suitable Lewis acid catalysts include AlBr3, A1C13, A1I3, GaCl3, FeCl3, SbCl5,
ZrCl4, SnCl4, BC13, BF3, SbCl3 and the like, preferably AICI3. The solvents used for this reaction include carbon disulfide, methylene chloride, nitromethane, 1,2-dichloroethane, nitrobenzene, and the like, preferably methylene chloride.
The ketone group of 6-bromo-2-tet ralone is protected by reaction with trimethyl orthoformate in a solvent, such as methanol, to provide the corresponding ethers according to the following Scheme 2. Hydrochloric acid, formed in situ by the addition of thionyl chloride acts as a catalyst in this reaction. One skilled in the art will recognize that other acid catalysts may be employed, for example, p-toluenesulfonic acid, phosphoric acid, etc. Temperatures from about 20 ° C to about 65 ° C are employed using standard cooling procedures.
SCHEME 2
The halogen-metal exchange is then provided by reacting the ethers protected by 6-bromo (A and B) with a reactive organolithium compound, preferably n-butylithium.
Alkylation of the resulting lithium species with an appropriate sulfur transfer reagent, for example, a sulfenyl halide or dimethyl disulfide, provides the ether protected by 6-met ilt io-2 -tet ralones. Deprotection is provided by methods known to those skilled in the art. A preferred method of deprotection is treatment with aqueous acid, preferably hydrochloric acid, to provide the desired 6-methylthio-2-tetralone compound (Schemes 3 and 4).
SCHEME 3
SCHEME 4
II All transformations, starting from 4-bromophenylacetic acid to the desired 6-methylthio-2-tetralone, can be carried out conveniently in a simple reaction flask without isolation of the intermediates. This improved process offers better yields, a reaction in a pot, the use of readily available reagents and is appropriate for large-scale production. The desired 6-met ilt io-2-tetralone can be isolated by standard methods, preferably by crystallization from the reaction mixture.
Alkylation and annulation aza.
A preliminary synthesis for the intermediate compound of formula VII
is taught in U.S. Pat. 5,239,075 and U.S. Patent Application. Serial Number 08 / 443,994, each of which is incorporated herein by reference. A further synthesis of the compound of the formula VII, of which this invention is an improvement, is shown in European Patent Publication 0564193. The methylitol group of the compound of the formula VII is located in the 8-position. This preferred process for preparing the The compound of the formula VII, described below, can be carried out without purification or isolation of the intermediates.
The 6-t iomet il-2-tetralone is reacted with (R) - (+) - phenethylamine to prepare the intermediate of formula III
The reaction is conveniently carried out at elevated temperature, particularly at reflux temperature, in toluene in the presence of a strong acid such as p-toluenesulfonic acid. The water that forms in this reaction must be removed, and the absence of water formed is an indication that the reaction has been completed. A slight excess of phenethylamine should be used, such as about 1.05-1.10 equivalents. Alternatively, tetrahydrofuran can be used as the solvent, and it is particularly convenient in the case of using molecular sieves for dehydrating the reaction mixture, using at least twice the weight of the molecular sieves compared to the amount of water that is released by the process .
The above phenethylamino compound is made of lithium with, for example, lithium n-butyllithium or diisopropylamide to provide a compound of formula IV
When the reaction is carried out, as preferred, with lithium diisopropylamide, the best results are obtained if the lithium diisopropylamide is freshly generated from diisopropylamine and n-butyllithium immediately before being used in the process. A substantial excess, about 15-25%, of lithium diisopropylamide is used for the best results.
The reaction of the lithium diisopropylamide is best carried out in rahydrofuran at a low temperature in the range of about -100 ° to about 0 °, preferably about -78 ° to about -10 °. The phenethylamino compound does not need to be purified or isolated, but the first reaction mixture must be evaporated under vacuum and the residue is taken up in tetrahydrofuran. It is preferred to add the phenethylamino material, in a solution, to a solution of lithium diisopropylamide in cold tetrahydrofuran; the contrary way of adding it is operable but it provides low yields. In general, the reaction can be carried out in less than one hour.
The lithium compound is difficult to isolate and purify, and should be introduced into the process of the present invention as a solution in the lithiation reaction mixture.
Alkylation
The lithium compound is methylated, for example by reacting the resulting lithioenamine with methyl iodide to provide the compound of the formula V
: "i» v ",
Dimethyl sulfate, methyl bromide, methyl chloride, methyl iodide, and the like can be employed to methylate the lithioenamine. It is convenient to use about 15-25% excess of methyl iodide, and to carry out the process in a solvent, preferably an ether solvent, such as diethyl ether, methyl t-butyl ether or, preferably, tetrahydrofuran . The reaction is very rapid at low temperatures in the range of about -100 ° to about -50 °, more preferably, about -80 ° to -60 °. Reaction times in the range from about a few minutes to about an hour are adequate, and a reaction time of 20 minutes is preferred.
If the lithium compound is in the form of the reaction mixture from lithiation with lithium diisopropylamide, and the reaction mixture therefore contains the excess diisopropylamine, the amine must be neutralized before methylation. More conveniently, the mixture of methyl iodide is allowed to warm to a temperature close to 0 °, and a sufficient amount of methanesulfonic acid is added to neutralize the diisopropylamine. Other strong acids can be used, but methanesulfonic acid is particularly convenient and is preferred because the methanesulfonate salt resulting from the diisopropylamine is only slightly soluble and therefore can be easily removed by simple filtration or centrifugation.
Nail override step
The reaction mixture comprising the compound of the formula V is combined with an acyl halide or an acrylic acid anhydride or acryloyl chloride, or the like, to initiate the aza nullification reaction forming the compound of formula VI
It is better to generate the acrylic anhydride, the preferred reagent, immediately before use by the reaction of acryloyl chloride and acrylic acid, using triethylamine and stabilizers, such as hydroquinone and butylated hydroxytoluene, in tet rahydrofuran.
Aza nullification is carried out by adding the acylic anhydride or acryloyl chloride to a very low temperature, such as from about -100 ° to about -70 °, and allowing the mixture to warm very slowly with stirring to a temperature in the range of about -20 ° to about 0 °, or even to about 10 ° -20 ° C. A period of time of 12-15 hours is reasonable to allow the mixture to warm. has been completed as desired, the reaction is quenched by the addition of solid sodium bicarbonate, use is preferred from about 1.5 to about 4 equivalents of base, more preferably about 2 equivalents. solution, for example, in water or in an aqueous solvent such as water / dimethylaminopyridine, but it is preferred to add the base in solid form.The reaction mixture is stirred with the base turned off for a short period, and then the mixture is filtered, the volatiles are removed, and the solvent can be replaced with an ether solvent, preferably diethyl ether, and the organic solution can then be worked by washing with an aqueous base and aqueous acid, and perhaps with steps of additional purification such as a wash with a saturated saline solution. If such working steps are used, the solution is then dehydrated and evaporated under vacuum to obtain the non-volatile portions of the reaction mixture, containing the final intermediate of formula VI.
On the other hand, the residue of the quenched reaction mixture can be taken out of work, if desired.
Reduction-partition step.
The residue of the aza nulling step is cooled, and a cooled mixture of an appropriate silane and trifluoroacetic acid is added. A suitable silane is a soluble silane, for example a dialkylsilane or tialkylsilane or the like. The addition takes place at a low temperature in the range from about -40 ° to about 0 °, and no other solvent is used. A large amount of trifluoroacetic acid, in the range of about 10-50 equivalents, more preferably about 20-30 equivalents, is used. The preferred trialkylsin is t-riet ilsilane, although trimethsilylsilane, t-isopropylsilane and the like can also be used. A substantial excess of tialkylsilane is used, in the range of about 5-20 equivalent, more preferably about 7-15 equivalents. The mixture is stirred for about 10-20 hours while allowing it to slowly warm to about 30 °, and then the mixture is slowly heated to an elevated temperature, preferably reflux temperature, and stirred at this temperature for a few hours. , such as about 2-6 hours to complete the formation of the compound of formula VII
Purification
The residue containing the product of formula VII can be dissolved, preferably in a haloalkane such as dichloromethane, washed with a base, such as aqueous sodium bicarbonate, and concentrated under vacuum. The purification is provided by recrystallization from, for example, ethyl acetate and methyl t-butyl ether or acetone or the like.
N-alkylation process
It is necessary in the synthesis to methylate nitrogen in position 4 in the benzo [f] quiniline ring. The U.S. Patent 5,239,075 shows such alkylation by a reaction with alkyl iodide in the presence of a strong base such as sodium hydride. An additional alkylation is shown in EPO publication 0703221.
N-methylation comprises reacting a compound of formula VII with a methyl halide, for example, methyl iodide in a reaction mixture comprising an organic solvent, for example a solvent selected from the group consisting of tetrahydrofuran, dimethoxyethane , diethoxyethane and methyl t-butyl ether, and a base, for example, potassium t-butoxide and tetrahydrofuran, aqueous sodium or potassium hydroxide, to provide a compound of formula VIII
This alkylation process allows an effective alkylation, under benign and easily controlled conditions, and allows an easy isolation of the products.
The alkylation process is carried out in a conventional chemical plant equipment, preferably at ambient pressure and at moderate temperatures. Preferably it is made by mixing the starting material of the formula VII in the organic solvent at a temperature close to that of the environment, such as from about 0 ° to about 50 °, more preferably from about 15 ° to about 25 ° . The most preferred organic solvent is tetrahydrofuran, and it is preferred to use about 5-15 liters of the solvent per kilogram of starting material; more preferably, the volume of the solvent is about 10 liters per kilogram. The alkyl iodide is then added as a pure liquid. A substantial excess of alkyl iodide is preferably used, such as about 1.2-1.8 equivalents based on the starting material, more preferably about 1.5 equivalents.
The aqueous sodium or potassium hydroxide is then added, still at room temperature, in an amount of about 1-4 liters per kilogram of the starting material. The amount of aqueous base is somewhat dependent on the concentration of the base and the choice of sodium or potassium hydroxide; when the most preferred base is used, 50% sodium hydroxide, the most preferred amount thereof is about 2 liters per kilogram of starting material. So, the reaction medium, consisting of solid material mixed in two liquid phases, is warmed to about 25-26 ° with vigorous stirring and the reaction is allowed to proceed at about a constant temperature with stirring. The preferred reaction temperature is ci'2 about 35-40 °. As the reaction proceeds almost to completion, the solid starting material and the alkyl iodide dissolve and react, so that the disappearance of the solids is a crude indication that it was completed. The reaction can be followed by high pressure liquid chromatography on a C-18 silica gel column, eluting with acetonitrile: aqueous 1: 1 saline solution (5% ammonium acetate) and observed at 220 nanometers.
When the reaction is desired to be near completion, the mixture is cooled to about room temperature and the aqueous layer is separated and discarded.
A preferred purification and isolation process proceeds by diluting the organic layer with water, and neutralizing it with aqueous mineral acid. Then the solution is distilled until the steam temperature reaches about 69-80 °, removing most of the tetrahydrofuran. Slow cooling to about 5 ° for a period of about 1-14 hours crystallizes the product, which only needs to be washed with water and dried to be ready for use as an intermediary or as a pharmacist. The most preferred isolation and purification is the recrystallization of the residue after removal of the tetrahydrofuran with ethyl acetate.
The alkylation process provides the product in the same stereochemical manner as the starting material, in a satisfactory purity for the pharmaceutical industry, and in yields of up to 90% when operated in accordance with preferred manners.
Electrophilic coupling
The electrophilic coupling of the Rl substituent to the sulfur group in the benzo [f] quinolinone ring can be provided in accordance with the following Scheme V.
SCHEME V,
VIII IX
wherein R1 is as defined above in formula I.
Oxidize (+) - (4aR) - (lObR) - - methyl - 8 - met ilt io - 10b - methyl - l, 2, 3,, 4a, 5, 6, lOb - octahydrobenzo [f] quinolin - 3 ona for a sulfoxide compound. M-chloroperoxybenzoic acid is a preferred oxidizing agent. With or without isolation, the sulfoxide compound is subjected to a Pummerer reaction as taught by Young et al., Te t ra h edron Le t t. 25, 1753 (1984), such that the sulfoxide reacts with an acylating agent, such as trifluoroacetic anhydride, to provide a trifluoroacetyloxymethyl sulfide compound (X). The trifluoroacet-yloxymethyl sulfide compound is reacted with an electrophilic reagent, a hydride-reducing reagent, such as sodium borohydride, potassium borohydride, lithium borohydride or the like, and a base, preferably a hydroxide or carbonate, more preferably , potassium carbonate, to prepare a compound of formula I. For the purpose of this reaction, suitable acylating agents include acyl halides, such as, acetyl chloride, sulfonic acid halides, reactive anhydrides, such as, trichloroacetic anhydride, phosphoric acid anhydride, sulfonic acid anhydride and similar agents capable of yielding a Pummerer reconfiguration product.
By the methods known in the art, the electrophilic reagent is replaced with a partition group, such as halogen, sulfate, sulfonate or the like. The electrophilic reagent is then coupled to the sulfur in the benzo [f] quinolinone ring. The preferred electrophilic reagent is 2-chloro-4-ethylbenzothiazole and this reagent is coupled with the compound of formula X to provide the (+) - (4aR) - (lObR) -4-methyl-8- (4-ethyl) -2-benzothiazolium) -lOb-methyl-1, 2, 3, 4, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one.
Preferably a catalyst, for example tetrabutylammonium hydrogen sulfate, is used to direct the coupling of the trifluoroacetyl yloxymethyl sulfide with the electrophilic reagent. Sodium borohydride has been found to induce the reduction of trifluoroacetylloxymethyl sulfide compound. Also, formaldehyde is generated if it is environmentally and pharmaceutically unacceptable. The present process reduces formaldehyde as it is formed for methanol. Also, in accordance with the present process, disulfides formed from oxidation to air are reduced in s i t u. This step of the process allows the starting materials to use more completely and rigorously exclude oxygen, or impurities that promote oxidation, if they are unnecessary. The addition of the base to the mixture is not essential to promote the coupling. However, the decomposition of borohydride is slow, and the relative coupling ratio is accelerated, adding a base.
The following preparations further illustrate the present inventive process. The preparations are not intended to limit the scope of the invention in any way and are not constructive.
Unless otherwise noted, the starting materials are obtained from commercial suppliers and used without further purification. Toluene, dimethylformamide, and methylene chloride are stored on 4Á molecular sieves. The reactions use organometallic reagents where they run under nitrogen. The reactions are observed by high pressure liquid chromatography using the conditions specified below. Thin layer chromatography is given using Merck Silica Gel 60 trays with a fluoiscent indicator (F254). The 1H and 13C NMR spectra are recorded on a General Electric QE or Bruker 300 MHz spectrophotometer at room temperature using CDC13 as solvent unless otherwise specified. The chemical changes of NMR were recorded in ppm with a solvent as the internal standard in the scale d and the J values are in Hertz. The IR, UV, and Mass Spectrometry (MS) analyzes are given by the Eli Lilly Physical Chemistry Laboratory. The conditions of high pressure liquid chromatography are: Intelligent pump model L-6200A of Hitachi with a chromatointegrator D-2500. Column RX C-18 Zorban of 25 cm, 60:40 of CH3CN / H20, 1.0 mL / minute, 275 nm, Injection - 10 uL. Gas chromatography (GC) conditions: HP 5890A GC with DB1 column 0.25 μ x 25 m; injection temperature 300 ° C; 300 ° C detection (FID); column at 5 ° C (5 minutes), 18 mL / minute up to 250 ° C and then at 250 ° C for 20 minutes. The terms "NMR", "MS", "IR" and / or "GC" indicate that the spectrum of the product was analyzed and is consistent with the desired structure.
Preparation 1
The 6-bromo-2-methyl yl ethers (A and B) 6-methylthio-2-methyl ethers (C and D) and 6-met ilt io-2-tetralone (11). The trimethyl ilortoformate (26.7 mL, 0.24 mol) and thionyl chloride (260 mg, 2.2 mol) are added to a thick mixture of 6-bromo-2-tetralone (50 g, 0.22 mol) in methanol (500 mL) under an atmosphere of nitrogen. After stirring 3-5 hours at room temperature, the solvent was removed under reduced pressure. The heptane (500 mL) was added to the residue and the solvent was removed again under reduced pressure to yield a residual oil.
The residual oil was dissolved in tetrahydrofuran (400 mL) and cooled to -78 ° C under a nitrogen atmosphere. The n-butyllithium (1.3 M in hexanes, 190 mL, 0.24 mol) was added to the solution after 15 minutes later by the slow addition of methyl disulfide (23.8 mL, 0.26 mol). The mixture was stirred 10 minutes at -78 ° C and then allowed to warm at 10 ° C for 45 minutes. After the addition of IN hydrochloric acid (200 mL) the mixture was concentrated under reduced pressure in a rotary evaporator (bath temperature 45 ° C) for 1 hour. The additional tetrahydrofuran (50 mL) was added to the mixture and the concentration was continued until the hydrolysis of the enol ether intermediate was completed in accordance with the GLC. The mixture was then extracted with ethyl acetate (2 x 100 mL). The ethyl acetate layers were dried over Na 2 SO 4 and concentrated under reduced pressure to a volume of 50 mL. The heptane was added slowly to the concentrated ethyl acetate and the resulting crystals were stirred 1 hour at 0 ° C, filtered, and dried to afford 30.6 g of 6-methylthio-2-tet ralone (72% yield), mp 57-58 ° C GLC 99.5%.
Preparation 2a
(+) - (4aR) - (10bR) -8-met ilt io-lOb-met il- 1, 2, 3, 4, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one.
A solution of 6-met ilt io-2-tet ralone (1 gram, 5.2 mmol, 1 equivalent) in dry toluene
(18 mL) was treated with (R) - (+) -fenet-ilamine (0.72 mL, 5.7 mmol, 1.1 equivalent) and p-TsOH (6 mg).
The solution was degassed 3 times with light vacuum / nitrogen and a positive nitrogen pressure was maintained. The solution went to
t * «^,,", - ^^, ".a-_, A -».,.
Reflux temperature under Dean-Stark conditions to remove water. The progress of imine formation was monitored by NMR. After 2.5 hours of reflux temperature, no starting ketone could be detected by 1R NMR. The toluene was completely distilled with a light vacuum and under nitrogen carefully not exposing the mixture to the air. Dry tetahydrofuran (14 mL) was added to obtain a light purple solution which was maintained at -70 ° C under nitrogen. The lithium diisopropylamide was generated by the dropwise addition of 2.5 M hexanes in a solution of n-butyllithium (2.4 mL, 6.0 mmol, 1.15 equivalent) to a solution of diisopropylamine (0.78 mL, 6.0 mmol, 1.15 equivalent) in tetrahydrofuran. (19 mL) at -45 ° C under nitrogen. The temperature was maintained between -45 ° C and -30 ° C during the addition. After addition, the solution was stirred for 10 minutes at -45 ° C. During the cooling of the lithium diisopropylamide solution at -75 ° C, the imine solution was added dropwise for 15 minutes through cannula while maintaining the temperature between -70 ° C and -75 ° C. The resulting orange-yellow lent solution was allowed to warm to -20 ° C for 20 minutes and then cooled again to -75 ° C. Iodomethane (0.36 ml, 5.8 mmol, 1.15 equivalent) was added between -75 ° C and -72 ° C. The solution was warmed (with the aid of an acetone bath) for 15 minutes at 0 ° C. During re-cooling at -5 ° C, methane sulphonic acid (0.43 mL, 6.6 mmol, 1.3 equivalent) was added for 2 minutes between -5 ° C and 1 ° C. After 5 minutes at 0 ° C, a gray heterogeneous mixture resulted. The mixture was re-cooled to -75 ° C. A 1.125M tetrahydrofuran solution of acrylic anhydride (11 mL, 12.5 mmol, 2.4 equivalents) was added rapidly. The mixture was kept in the cooling bath for 15 hours, during which time it was heated to 13 ° C. The reaction was allowed to warm to 15 ° C. Water (2 mL) was added and the mixture was stirred while the mixture was warmed to room temperature. The solution was diluted with diethyl ether (50 mL) and washed successively with IN sodium hydroxide (20 mL), IN hydrochloric acid (20 mL), water (20 mL), saturated aqueous sodium bicarbonate (40 mL), and brine (20 mL). The sodium sulfate solution was dried, concentrated and flash chromatographed on silica gel (120 grams), eluting with 70:30 ethyl acetate / hexanes) to obtain 1.3 grams of (69% yield) of (+ ) - (lObR) -4 - (2- (R) -phenethyl) -8-methylthio-10b-methyl-1,2,3,6,9-hexahydrobenzo [f] quinolin-3-one (RMN). A mixture of triethylsilane (12 mL, 75 mmol) and trifluoroacetic acid (14.5 mL, 188 mmol) previously cooled to -15 ° C under nitrogen was added to (+) - (10bR) -4- (2- (R) - phenethyl) -8-met ilt io-lOb-met il-1, 2, 3, 4, 6, lOb-texahydrobenzo [f] quinolin-3-one (2.76 grams, 7.6 mmol) previously cooled in a -15 bath ° C. The mixture was stirred for 15 hours during which time it was warmed to 13 ° C. Thin layer chromatography (70:30 ethyl acetate / hexanes) and high pressure liquid chromatography showed complete disappearance of (+) - (10bR) -4- (2- (R) -phenethyl) -8- meti 11i-1 Ob-meti 1-1, 2, 3, 4, 6, lOb-hexahydrobenzo [f] -quinolin-3-one and the appearance of a new product, indicating the reduction of double complete binding. The mixture was then refluxed for 2 hours to remove the auxiliary chiral. During cooling to room temperature, the mixture was concentrated under reduced pressure. The residue was taken up in methylene chloride (50 mL) and washed twice with saturated aqueous sodium bicarbonate (35 L) and brine (50 mL). The sodium sulfate was dried and the crude crude product was purified by flash chromatography on silica gel (100 grams), eluting first with 3: 1 ethyl acetate / hexanes to remove triethylsilane and then with 14% methanol in chloride of methylene with 1% acetic acid to obtain a foamy solid. Recrystallization from hot ethyl acetate gave 1.6 grams (82%) of (+) - (4aR) - (10-R) -8-met-ilthio-O-methyl-1, 2, 3, 4, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one (92% ee, IR, NMR, MS). Calculated for C15H19N0S; C, 68.93; H, 7.33. Found C, 69.05; H, 7.44.
Preparation 2b
(+) - (4aR) - (10bR) -8-methylthio-lOb-methyl-1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one.
A solution of the compound 6-met ilt io-2-tetralona (9.6 g, 50 mmol), p-toluenesulfonic acid monohydrate (40 mg, 0.2 mmol) and R - (+) - a-met i lben zylamine (6.64 g) , 55 mmol) in toluene (150 mL) was heated to reflux temperature. The water generated during the reaction was removed through a Dean-Stark network. The progress of the reaction was monitored by NMR (300 mHz, CDC13) which indicated 100% conversion after 2 hours of reflux temperature. The enamine solution was concentrated to a volume of 30 mL by atmospheric distillation. The enamine solution was then cooled to -78 ° C, diluted with tetrahydrofuran (100 mL) and added via canula to a solution of lithium diisopropyl amide (2.0 M in heptane / THF) (28.7 mL, 57.5 mmoles) and tetrahydrofuran (130 mL). After stirring for 30 minutes at 78 ° C, iodomethane (3.6 mL, 57.5 mmol) was introduced and stirring continued for another 30 minutes at -78 ° C. The methanesulfonic acid (4.05 mL, 62.5 mmol) was added followed by a warming of the reaction mixture at 0 ° C. In a separate vessel, acrylic acid
(6.6 g, 91.5 mmol) was added slowly to a solution of triethylamine (9.25 g, 91.5 mmol), hydroquinone (0.11 g) and 2,6-di-tert-butyl-4-methylphenol (0.11 g) in tetrahydrofuran ( 100 mL) a
-10 ° C to -15 ° C. Trimethylacetyl chloride
(11.0 g, 91.5 mmol) was added slowly, maintaining the temperature at less than -5 ° C. The reaction mixture was stirred 2 hours at -10 ° C, then filtered and the filtered solids were washed with 20 L of tetrahydrofuran. The filtrate and sodium bicarbonate (NaHCO3) (9.2 g, 110 mmol) were added to the enamine solution and the resulting mixture was stirred at 0 ° C for 4 hours. Deionized water (190 mL) was added and stirring continued for 0.5 hours at 0 ° C. the solvent was then removed by vacuum distillation (temperature < 30 ° C). Methylene chloride was added
(90 mL) and the layers separated. The methylene chloride layer was washed sequentially with a solution of IN NaOH (4 x 25 mL), an IN hydrochloric acid solution (20 mL) and a saturated sodium bicarbonate solution (20 mL). The solvent was then removed from the reaction mixture by vacuum distillation (temperature < 30 ° C). Triethyl-silane (80 mL, 500 mmol) and trifluoroacetic acid (100 mL, 1.3 mol) were added and the resulting mixture was stirred at 27-32 ° C for 12 hours followed by 6 hours at reflux temperature. The progress of the reaction was monitored by HPLC (such as 25 cm of Supelcosil LC-ABZ, 40% isocratic deionized water / 60% acetonitrile, 220 nm, 2 mL / minute) which indicated a> 95% conversion The reaction mixture was then concentrated by vacuum distillation to about 70 mL and diluted by the addition of acetonitrile (70 mL). The acetonitrile solution was washed with heptane (6 x 25 mL). The acetonitrile was removed by vacuum distillation and the residue was dissolved in methylene chloride (50 mL). A saturated solution of sodium bicarbonate (150 L) was added slowly and the layers separated. The methylene chloride layer was washed with a solution of sodium bicarbonate (150 mL) and the solvent was removed by vacuum distillation. The residue was diluted with ethyl acetate (40 mL) and the resulting mixture was stirred at -30 ° C for 1 hour. The mixture was filtered and the filter cake was washed with cold ethyl acetate (-30 ° C) (10 mL) followed by drying at 50 ° C to give 6.22 g (49%) of (+) - (4aR) - (lObR) -8-methylthio-10b-methyl-l, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one (GLC purity 99.5%).
Preparation 3 (+) - (4aR) - (lObR) -4-methyl-8-methylthio-10b-methyl-l, 2,3,4,4a, 5,6,10b-octahydrobenzo [f] quinolin-3- ona
(+) - (4aR) - (lObR) -8 -methylthio-1 Ob-met i 1-1, 2, 3, 4, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one (0.423 grams, 1.62 mmol, 1.0 equivalents) was treated with potassium t-butoxide (1.86 mL as a 1.0 M solution in tetrahydrofuran), 1.15 equivalents) in dimethylformamide (1.6 mL) at about 0 ° C. After stirring 5 minutes, methyl iodide (0.116 mL, 1.15 equivalents) was added and the mixture was allowed to stir for 2 hours at 0 ° C. The mixture was then treated with about 100 mg of acetic acid and the solvents were removed in a stream of nitrogen. The solid was dissolved in about 50 mL of methylene chloride and washed twice with water. The extracts were dried (molecular sieves 4) and filtered on silica gel (2 grams, washed with ethyl acetate containing 2% methanol). The solid from the evaporation of the methylene chloride extracts was chromatographed on silica gel with methylene chloride, ethyl acetate and methanol (50: 50: 1) as the eluent. (GC).
Preparation 4
(+) - (4aR) - (lObR) - -methyl- 8- (4-ethyl-2-benzothiazolylthio) -10b-methi 1-1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [ f] quinolin-3-one.
A solution of meta-chloroperoxybenzoic acid
(about 56% strength, 6.32 grams as a methylene chloride solution) was added to the mixture of (+) - (4aR) - (1 ObR) -8-methylthio-10b-methyl-1,3, 4,4a, 5,6,10b-octahydrobenzo [f] quinolin-3-one. (5.50 grams in 110 mL of methylene chloride) and aqueous sodium bicarbonate (9.4 grams in 110 mL of water) at 0 to 1 ° C for about one hour. After 8 horde, the layers were separated and the organic extracts were washed twice with 1% aqueous sodium bicarbonate, dried
(Molecular sieves 4Á) and evaporated to a total weight of 5.90 grams. A portion (2.91 grams) of this unpurified sulfoxide in 10 L of toluene-ds sa treated with 2.20 mL of trifluoroacetic anhydride at 5-10 ° C. after 30 minutes, the XH NMR analysis of an aliquot of 0.50 mL did not show the starting sulfoxide (absent singlet of ArSOCH3 at d = 2.25 ppm) and the exclusive formation of the Pummerer Product (ArSCH2OCOCF3, singlet at d = 5.31 ppm). The reaction mixture was subjected to vacuum (5-10 torr) for 30 minutes after which the contents were added to a stirred mixture (under nitrogen) of water (20 mL), tet ra-n-but hydrogen sulfate ilamonium (0.1 gram), and 7.1 mL of water-soluble borohydride (12% by weight of sodium borohydride in 14 N sodium hydroxide) at 5-10 ° C for 20 minutes. After an additional 20 minutes, 2-chloro-4-ethylbenzothiazole (3.00 grams with an additional 9.5 mL of toluene-ds) and another portion of tetra-n-butylammonium hydrogen sulfate (0.50 gram) were added. The reaction was stirred at 37-39 ° C during which four 0.25 mL portions were removed by direct 1 H NMR test and high pressure liquid chromatography by analysis of product conversion and distribution. After 26 hours, the uppermost layer (toluene containing (+) - (4aR) - (10 bR) -4 -met i 1-8- (4 -eti 1-2 -benzot ia zol i lt io) -10b -methyl-1, 2, 3, 4, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one and an excess of 2-chloro-4-ylbenzothiazole) of the three-phase mixture, separated and diluted with 25 mL of methylene chloride. This organic layer was washed with IN aqueous sulfuric acid, 5% aqueous sodium bicarbonate, dried with 4 A molecular sieves, concentrated in vacuo to 5.24 grams. The resulting solid was taken up in warm methyl t-butyl ether (30 mL) after which it was concentrated under vacuum to 20 mL and then cooled to 0 ° C. The mixture was filtered and the white solid was dried to give 2.92 grams of (+) - (4 aR) -lObR) -4-met il-8 - (4-yl-2-benzothiazolylthio) -lOb-met i 1- 1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one (IR, NMR, MS). Calculated for C 24 H 26 N 2 OS 2: C, 67.93; H, 6.16; N, 6.83; S, 15.08. Found C, 68.21; H, 6.20; N, 6.63; S, 15.17.
Preparation 5
(+) - (4aR) - (10bR) -4 -met-il-8- (4-ethyl-2-benzothiazolium) -10b-methyl-1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one.
A solution of meta-chloroperoxybenzoic acid
(35.2 mmoles in 100 mL of methylene chloride) was added to (+) - 4aR) - (lObR) -mt-il-8-met ilt io-lOb-methyl-l, 2,3,4,4a, 5, 6,10b-octahydrobenzo [f] quinolin-3-one (10.0 grams, 98% pure by heavy standard power assay,
. 6 mmole) in a biphasic mixture of methylene chloride (200 mL) and aqueous sodium bicarbonate.
(8.90 grams in 89 mL of water) at -2 to 0 ° C for a period of 1 hour. The layers were separated and the methylene chloride layers were washed once with sodium metabisulfide (1.00 grams in 25 mL) and three times with sodium bicarbonate (1.00 grams in 100 mL). The dried methylene chloride extract (4Á molecular sieves) was concentrated to approximately 20 mL and diluted with 100 mL of toluene. The mixture was then concentrated under vacuum at 30-35 ° C. This process was repeated twice with fresh toluene (100 mL each portion) after which the sulfoxide (usually crystalline) was diluted with toluene (100 mL). The mixture was then treated with trifluoroacetic anhydride (7.30 mL) for 10 minutes at 0 to 10 ° C. After 30 minutes at 0 ° C, this solution was subjected to vacuum (<10 torr) for 30 minutes and added for 30 minutes to a degassed (nitrogen) mixture of potassium carbonate (41 grams), sodium borohydride (2.88 grams), tetra-n-butylammonium hydrogen sulfate (2.00 grams) , and 2-chloro-4-ethylbenzothiazole (8.20 grams at 96.5% purity dissolved in 5 mL of toluene) and water (87 mL) at 0-5 ° C. The mixture was heated to 40 ° C for one hour and then stirred at 40 ° C for 26 hours. The toluene layer was separated (while it was lukewarm) and washed with 3xl00-mL portions of water. The toluene layer was diluted with 125 mL of ethyl acetate and then washed sequentially with portions of 3x200 mL of 0.25N hydrochloric acid, 100 mL of 1% sodium bicarbonate and 100 mL of saturated aqueous sodium chloride. The organic layer was dried (10 grams of molecular sieves 4A), concentrated to a total volume of 25 mL and treated with 100 mL of methyl t-butyl ether (at reflux temperature for 30 minutes then, at 0 ° C. for 1 hour) provided (+) - (4aR) - (lObR) -4-methyl-8- (4-ethyl-2-benzothiazolylthio) -lOb-met il-1, 2, 3, 4, a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one.
Preparation 6
(+) - (4aR) - (10bR) -4-methi 1-8- (4-ethyl-2-benzothiazolium) -10b-methyl-1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one.
Dry sulfoxide IX (96% purity by gas chromatography, 8.90 grams, corrected 29.4 mmol) as a suspension in toluene (89 mL) was treated dropwise with trifluoroacetic anhydride (5.2 mL) at 0-5 ° C at 20 ° C. minutes (dissolution occurred). After 30 minutes, the solution was added to the mixture of potassium carbonate (32 grams), water (45 mL), tetrabutylammonium hydrogen sulfate (2.25 grams), sodium borohydride (1.0 grams), 2-chloro- 4-ylbenzothiazolo (7.07 grams, approximately 96.5% purity by gas chromatography), and toluene (10 mL) at about 5-15 ° C for 30 minutes. The biphasic mixture was then stirred for 20 hours at 43 ° C after which a small amount of solid was filtered out of the reaction mixture. The warm toluene layer was washed once with 400 mL of water (45 ° C) and then evaporated under vacuum with 13.86 grams of a
"Ja, -sÜS, 0» a¿ai3p- -, a. * -? and.
white solid consisting mainly of (+) - (4aR) - (lObR) -4-met i 1-8- (4-ethyl-2-benzothiaolthio) -10b-methyl-1, 2, 3, 4, 4a, 5 , 6, 10b-octahydrobenzo [f] quinolin-3-one and 2-chloro-4-ethylbenzothiazole. 13.0 grams of this mixture were treated with methyl t-butyl ether (50 mL at reflux temperature and then at 0 ° C for 2 hours) yielding 11.05 grams of (+) - (4aR) - (lObR) -4-methyl -8- (4-ethyl-2-benzothiaolthio) -10b-methyl-1, 2,3,4,4, 5,6,10b-octahydrobenzo [f] quinolm-3-one (IR, NMR, MS) . Calculated for C, 68.21; H, 6.20; N, 6.63. Found C, 68.29; H, 6; N, 6.67.
Preparation 7
(+) - (4aR) - (10bR) -4 -met i 1-8- (4-ethyl-2-benzothiazol) -10b-methyl-1, 2,3,4,4a, 5,6, 10b-octahydrobenzo [fj quinolin-3-one.
Meta-chloroperoxybenzoic acid
(approximately 92 grams, approximately 50% power, in 1.0 L of methylene chloride) was added at 0 ° C to a solution of (+) - (4aR) - (10bR) -4-met? l-8-met ? l ti or -10b-methyl-1, 2, 3, 4, 4a, 5, 6, 10b-octahydrobenzo [f] quinolin-3-one (79.5 grams, 92.9% strength, 0.269 moles) in methylene chloride (2.2 L). The progress of the reaction was monitored by high pressure liquid chromatography (240 nm) by the oxidation of (+) - (4aR) - (lObR) -4-methyl-8-methylthio-10b-methyl- 1, 2, 3 ,, 4a, 5, 6, lOb-octahydrobenzo [f] quinolin-3-one to a level of less than 0.3% per area. The organic solution was stirred with a solution of sodium bisulfate (75 grams in 1 L of deionized water). The organic layer was separated, and washed with a 6% sodium bicarbonate solution (3 x 1 L). The organic layer was dried over sodium sulfate and concentrated. Toluene (1 L) was added to the intermediate sulfoxide and this solution was concentrated under vacuum. This was repeated twice with fresh toluene (1.1 L each) after which the sulfoxide was dissolved in 1.1 L of toluene and cooled in an ice bath. Trifluoroacetic anhydride (51 mL) was added dropwise to the sulfoxide at 0 ° C for 15 minutes. After 30 minutes of stirring at 0 ° C, the Pummerer product
(ArSCH2OCOCF3) was added through a cannula to a well-stirred mixture of deionized water (414 mL), potassium carbonate (319 grams), sodium borohydride (15.2 grams), 2-chloro-4-ethylbenzothiazole (65.7 grams) approximately 96.5% purity), tetrabutylammonium hydrogen sulfate (21.6 grams), and toluene (170 mL) at 10 ° C. The reaction was slowly heated to 42 ° C while the progress was monitored by high pressure liquid chromatography. After 18 hours, an additional volume of toluene (1.0 L) was added and the toluene layers were washed with deionized water (3 x 1 L, 45 ° C). Ethyl acetate (1 L) was added to the organic layer, then the organic layer was washed with 0.25 M hydrochloric acid solution (3x1 L), IN sulfuric acid solution (3x1 L), 6% sodium bicarbonate solution. % (1.5 L), and saturated sodium chloride solution (2 L). The organic extracts were dried over 4Á molecular sieves (500 grams) and then concentrated. Methyl t-butyl ether (400 mL) was added and the mixture was heated to reflux temperature. After 30 minutes of stirring at reflux temperature, the mixture was cooled to 5 ° C. The suspension was filtered and washed with methyl t-butyl ether (100 mL). The solution was filtered and the product was dried at 50 ° C to about 5 mm for 18 hours
«M ^ ^ S ^ Ii» a) μ- »proprocionado 90.1 grams (80%) of (+) - (4aR) -lObR) -4-methyl-8- (4-ethyl-2-benzothiazoliltio) -10b- methyl-l, 2,3,4,4a, 5,6,10b-octahydrobenzo [f] quinolin-3-one.
It is noted that in relation to this date, the best method known to the applicant to carry out the aforementioned invention, is that which is clear from the present description of the invention.
Having described the invention as above, the content of the following is claimed as property.
Claims (5)
1-1, 2, 3, 4, 4a, 5, 6, 10b -octahydrobenzo [f] quinolin-3-one. 9. The process according to any of claims 2, 3, 4, 5 or 6, characterized in that it additionally comprises: reacting the compound of the formula II II with (R) - (+) - phenethylamine to provide a compound of the formula III reacting the compound of the formula III with a strong lithium base to provide a lithium-enamine compound of the formula IV methylating the resulting lithioenamine of formula IV to a compound of formula V reacting the compound of the formula V with an acyl halide or an acrylic acid anhydride to prepare the compound of the formula VI quenching the reaction with a base, and combining the residue comprising the compound of formula VI with an appropriate silane and trifluoroacetic acid in the absence of a solvent to prepare a compound of formula VII 10. The process according to claim 9, characterized in that it additionally comprises: reacting the compound of the formula VII with a methyl halide in a reaction mixture comprising an organic solvent and a strong base to provide an arylmethyl sulfide compound of the formula VIII CH3 by oxidizing the compound of the formula VIII to a sulfoxide compound of the formula IX reacting the sulphoxide compound of formula IX with an acylating agent to produce a Pummerer rearrangement product: reacting the Pummerer rearrangement product with an electrophile selected from the group consisting of A-R1 wherein A is a starting group and R1 represents:
2-nitrophenyl, 4-nitrophenyl, 2-cyanophenyl, 4-cyanophenyl, 2-nor tronaftyl, 4-nor tronaftyl, 2-cyanonaphthyl, 4-cyanonaphthyl, 2-quinolinyl, 4-quinolinyl, 7-quinol inyl, 1 - isoquinolinyl,
3-isoquinolinyl, 8-isoquinol inyl, 2-quinoxalinyl, 2-benzothiazolyl, 3-lH-indazolyl, 2-benzoxazolyl, 3- 1, 2-benzisothiazolyl, 2-pyridinyl,
4-pyridinyl, 2-pyrazinyl, 2 -naphtho [2,3-dithiazolyl, 2-naphtho [1,2-d] thiazole ilo, 9-anthryl, 2-thiazolyl, 2-benzimidazole, 1-benz [g] isoquinolinyl, 8 -benz [g] isoquinolinyl ,
5-lH-tetrazolyl, 2-quinazolinyl, 2-thia zolo [, 5-b] pyridinyl, 4-10H-pyridazino [3,2-b] -2-quinazolinyl, 2-1, 4-benzodioxinyl, 2- triazine, 2-benzoxazine, 4-benzoxazine, 2-purine or 8-purine; wherein the above groups of R1 are substituted or unsubstituted with 1-3 groups selected from the group consisting of trifluoromethyl, trifluoroethoxy, C? -C4 alkyl, trifluoromethoxy, hydroxy, C? -C3 alkoxy, nitro, alkylthio C? -C3, C? -C6 alkanoyl, f or lo, oxo, phenoxy, phenylthio, C1-C3 alkylsulfinyl, C? -C3 alkylsulfonyl, cyano, amino, C? -C3 alkylamino, diphenylmethylamino, triphenylmethylamino, benzyloxy, benzylthio, -halo, nitro or CF3) benzyl (oxy or thio), di (C1-C3 alkyl, C3-C6 cycloalkyl, or C4-Ce cycloalkylamino) amino, (mono-C? -C3 alkyl, C? -C3 alkoxy, or halo) (phenyl, phenoxy, phenylthio, phenylsul fonyl or phenoxysul foni lo), C2-Cd alkanoylamino, benzoylamino, diphenylmetylamino (C1-C3 alkyl), aminocarbonyl, C1-C3 alkylaminocarbonyl, di (C1-C3 alkyl) aminocarbonyl, halo -alkanyl Ci-C e, aminosulfonyl, alkylaminosul fonyl C1-C3, di (C1-C3 alkyl) aminosulfonyl, phenyl (oxy or thio) (C1-C3 alkyl), (halo, C-C3 alkyl or Ci-C3 alkoxy) ) faith nil (oxy or thio) (C 1 -C 3 alkyl), benzoyl, or (amino, C 1 -C 3 alkylamino or di (C 1 -C 3 alkyl) amino) (C 1 -C 3 alkyl); in the presence of a phase transfer catalyst, a hydride reducing reagent and a base, to prepare a compound of formula I. 11. A compound of formula A: 12. A compound to the formula B CH30 B. 13. A compound of the formula C 14 A compound of the formula D. «.-, *. or
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/089,749 | 1998-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA00012387A true MXPA00012387A (en) | 2001-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU226394B1 (en) | Process for the preparation of leukotriene antagonists and their salts | |
CZ234897A3 (en) | Process for preparing 1-(thiomethyl)-cyclopropanacetic acid | |
CN111511725B (en) | 1-cyano-2- (4-cyclopropyl-benzyl) -4-) (beta-D-glucopyranos-1-yl) -benzene Synthesis of 1:1:1 Co-crystals of L-proline and Water | |
US6111110A (en) | Synthesis of benzo[f]quinolinones | |
RU2114854C1 (en) | Derivatives of 4-chloro-2-thiophene carboxylic acid, method for production of 4-chloro-2-thiophene carboxylic acid (variants) and method for production of 5-fluoro-6-chloro-3-(4-chloro-2-thenoyl)-2-oxindole-1-carboxamide (variants) | |
EP0334695A1 (en) | Process for the preparation of isoquinoline derivatives | |
MXPA00012387A (en) | Synthesis of benzo[f]quinolinones | |
EP2142508A2 (en) | Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid | |
CZ294311B6 (en) | Reduction process of prochiral ketone | |
AU735651B2 (en) | Synthesis of benzo(f])uinolinones | |
CA2334701A1 (en) | Synthesis of benzo¬f|quinolinones | |
KR100302346B1 (en) | A method of preparing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline | |
MXPA99004067A (en) | Synthesis of benzo[f]quinolinones | |
CZ20004702A3 (en) | Process for preparing benzo[f]quinolinones | |
CZ153499A3 (en) | Process for preparing benzo[f]quinolinones | |
EP3521293B1 (en) | Process for the preparation of an inhibitor of phosphodiesterase 4 | |
EP0684234B1 (en) | Synthesis of benzoquinolinones | |
JPH0623176B2 (en) | Process for producing asymmetric dithioacetal and dithioketal | |
JP4358931B2 (en) | Method for producing 3-mercapto-1- (1,3-thiazolin-2-yl) azetidine | |
CZ20032633A3 (en) | Process for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate | |
WO1996036610A1 (en) | Synthesis of benzoquinolinones | |
JP2002053552A (en) | Method for producing 4,6-dimethylindole and derivative thereof | |
KR20050119145A (en) | Process for the production of imidazopyridin-8-ones |